Summary
A number of factors are driving growth in spinal orthopaedics, but none are more important than the fundamental shift from the current leading spine fusion treatments to disc replacement.
What's it all about?
Spinal fusion has become the standard surgical care for numerous pathologic conditions of the spine. Spinal fusion surgery is frequently performed to treat spinal disorders such as spondylolisthesis, scoliosis, degenerative disc disease (DDD), instability of the spine or spinal fractures.
An alternative to spinal fusion in the treatment of DDD, is an artificial intervertebral disc. Unlike spinal fusion which achieves pain relief through immobilisation, artificial discs maintain motion at the operative level once the damaged disc has been removed. By preserving normal physiological motion, it is thought this may also reduce or prevent the development of adjacent segment degeneration. In addition, a bone graft is not required for an artificial disc replacement and this alleviates complications such as bone graft donor site pain and pseudo-arthritis. Furthermore, artificial disc replacements provide a more rapid return to activity than fusion surgery which requires time for the bone graft to grow into a solid mass.
This report provides real insights...
For executives working in industry and commerce, the need to understand the issues, players and products in this sector of high growth potential is essential. That is why Espicom, for 25 years a leading publisher of strategic business information for the medical device community, has published this extensive report.
In over 175-pages, the report examines the background to market, provides key figures and estimates for market growth and examines in-depth the companies and innovative products that are driving change.
This report answers key business questions...
- What % of the market may be taken by the fledgling disc nucleus replacement market if it can overcome regulatory obstacles in the USA?
- What competitive impact will Medtronic's breakthrough have in the US cervical TDR market?
- What % of the global market will Dynamic Stabilisation Systems command in 2011?
- What is the potential for minimally-invasive spinal technology?
- Which development companies have the most promising and innovative technology and present the most attractive acquisition targets?
- To what degree will gene-based diagnostic testing affect the market in the future?
Providing...
- Comprehensive market forecasts of technology and application sectors to 2011
- A thorough review of the spinal orthopaedic market worldwide
An examination of key products that are currently in development:
- Total Disc Replacement
- Dynamic Stabilisation Devices
- Disc Nucleus Replacement
A competitive review of 63 companies actively developing spinal preservation products
|
